Aclaris Therapeutics to Participate in the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced that Dr. Neal Walker, President and CEO, will present at the Jefferies Virtual Healthcare Conference on June 1, 2021, at 1:00 p.m. ET. This presentation will provide an overview of the company's efforts in developing innovative drug candidates for immuno-inflammatory diseases. Aclaris' management will also be available for virtual one-on-one meetings throughout June 1st. The presentation can be viewed live on Aclaris' website, and the archive will be accessible for 30 days.

WAYNE, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will present a company overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 1:00 p.m. ET. Management will be available June 1st throughout the day for virtual one-on-one meetings.

A live video webcast of the presentation may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com

FAQ

What is Aclaris Therapeutics presenting at the Jefferies Virtual Healthcare Conference on June 1, 2021?

Aclaris Therapeutics will present an overview of its drug development efforts for immuno-inflammatory diseases at the Jefferies Virtual Healthcare Conference.

Who is the CEO of Aclaris Therapeutics that will present at the conference?

Dr. Neal Walker is the President and CEO of Aclaris Therapeutics.

When will Aclaris Therapeutics present at the Jefferies Virtual Healthcare Conference?

Aclaris Therapeutics will present on June 1, 2021, at 1:00 p.m. ET.

How can I access the Aclaris Therapeutics presentation from the Jefferies conference?

The presentation can be accessed via live video webcast on Aclaris' website under the 'Events' section.

Will the Aclaris Therapeutics conference presentation be available later?

Yes, the webcast will be archived for at least 30 days on Aclaris' website.